Evidence map›Paper›PMID 41572131›Full record

Observational studyCancer control : journal of the Moffitt Cancer Center

Ga-68-Edotreotide PET/CT SSTR Total Tumor Volume as a Predictor of Outcome in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors.

Rosj Gallicchio, Mariarita Milella, Alessia Giordano, Mauro Cives, Rebecca Storto, Anna Nardelli, Giovanni Calice, Matteo Landriscina, Giovanni Storto

Abstract readObservational Study
In one paragraph

Observational study in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rosj GallicchioNuclear Medicine IRCCS CROB, Referral Cancer Center of Basilicata, Rionero in Vulture, Italy.
Mariarita MilellaNuclear Medicine IRCCS CROB, Referral Cancer Center of Basilicata, Rionero in Vulture, Italy.
Alessia GiordanoNuclear Medicine IRCCS CROB, Referral Cancer Center of Basilicata, Rionero in Vulture, Italy.
Mauro CivesInterdisciplinary Department of Medicine, University of Bari "Aldo Moro", Bari, Italy.
Rebecca StortoNuclear Medicine IRCCS CROB, Referral Cancer Center of Basilicata, Rionero in Vulture, Italy.
Anna NardelliInstitute of Biostructures and Bioimages CNR, Napoli, Italy.
Giovanni CaliceLaboratory of Preclinical and Translational Research, IRCCS CROB, Referral Cancer Center of Basilicata, Rionero in Vulture, Italy.ORCID 0000-0002-2545-1401
Matteo LandriscinaUnit of Medical Oncology Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Giovanni StortoNuclear Medicine IRCCS CROB, Referral Cancer Center of Basilicata, Rionero in Vulture, Italy.ORCID 0000-0002-6168-5598

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IntroductionThe somatostatin receptor (SSTR) standardized uptake value (SUVmax

Indexed as

Intestinal NeoplasmsNeuroendocrine TumorsPancreatic NeoplasmsPositron Emission Tomography Computed TomographyReceptors, SomatostatinSomatostatinStomach NeoplasmsAdultAgedFemaleGallium RadioisotopesHumansMaleMiddle AgedOctreotidePrognosisEdotreotideGallium RadioisotopesOctreotideReceptors, SomatostatinSomatostatinmetastatic GEP-NETPET/CTquantitative assessmentsurvivalvolumetric parameters

Identifiers

PMID41572131
PMCPMC12833188

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.